The global HIV diagnosis market is expected to reach USD 11.76 billion by 2033, at a CAGR of 12.35% during the forecast period 2024-2033. Increasing prevalence of HIV/AIDS across the globe is one of the major factor driving the growth of market.
HIV stands for human immunodeficiency virus, which causes AIDS (acquired immunodeficiency syndrome). The Centers for Disease Control and Prevention (CDC) recommends that people in between age 13 to 64 should get tested for HIV at least once as part of a routine health test. The HIV diagnosis refers to the method for detection of the virus in the body. Blood tests are the most common way to detect and diagnose HIV. Generally, tests are done for the reason including individual diagnosis, protection of blood or tissue products safety, and public health surveillance. Early diagnosis of HIV is very important to prevent the further transmission of the disease and to begin the therapy.
There are three types of tests used to diagnose HIV infection. Antibody test, antigen/antibody test and NATs are some of the test used for the HIV diagnosis. The antibody test is usually used for the initial testing of HIV, while NATs are very expensive and cannot be used routinely until the person had high-risk exposure. HIV infection across the globe continue to be the major public health crisis. Thus, HIV diagnosis has become increasingly important to prevent further transmission of the disease. ELISA test, which stands for enzyme-linked immunosorbent assay, is one of the most common tests which is used to diagnose the HIV infection. When ELISA test detects the positive infection, the Western blot test is usually carried out to confirm the diagnosis. Hone test is also available for the diagnosis of HIV. Home Access Express Test, which is sold in pharmacies, is the only test approved by the U.S. Food and Drug Administration for the home HIV test.
Get an overview of this study by requesting a free sample
HIV prevalence is increasing rapidly in almost every geographic region and becoming one of the major public health crisis in the world. As per the U.S. Department of Health & Human Service data, there were about 37.9 million people across the globe with HIV/AIDS. Approximately 1.7 million individuals in the world are newly infected in the year 2018. Around 79% of total infected people are aware of their HIV infection, and 21% of people are still needed to access the HIV testing service. Therefore, increasing prevalence of HIV/AIDS across the globe driving the growth of the market.
The increasing various government initiative to prevent the further transmission of HIV is one of the key factor driving the demand for HIV diagnosis. Many governments across the globe are working hard to eradicate HIV/AIDS, which possess the serious public health risk. Efforts are now being made to bring down the HIV cases to zero. Thus, many governments are introducing new programs, diagnosis, and treatment for HIV/AIDS.
A nucleic acid test (NAT) tests looked for the actual testing of the virus in the blood rather than the antibodies. However, this test is very expensive and not used routinely for the HIV diagnosis. It used when the person had exposed to the high risk and have the early symptoms of HIV/AIDS. Thus, the high cost of NAT HIV diagnosis may hamper the growth of the market over the forecast period.
The diagnosis of HIV has been changed enormously from the past few years. The home test kits make it possible for the individual to access the kit at the pharmacies and to check the HIV infection at home. The home test kit has increased the convenience for the people and also helps to maintain their privacy. Thus, increasing the use of home test kit for the HIV diagnosis will provide further growth opportunities in the market.
East and southern Africa are one of the most highly affected regions for HIV/AIDS. However, there are not enough testing centres available for the diagnosis of HIV. In addition to this, many people still not aware of their HIV status, due to lack of awareness. In addition to this, many underdeveloped countries do not have enough laboratories and skilled professionals for the testing and diagnosis of HIV, which is hampering the growth of the market over the forecast period.
The global HIV diagnosis market has been segmented based on type, technology, end use, and regions.
The regions analyzed for the global HIV diagnosis market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region accounted for the major market share of 39.28% in the year 2023.
North America HIV Diagnosis Market Share in 2023 - 39.28%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The key players of global HIV diagnosis market are majorly focusing on adoption of various strategies such as new product development, joint venture, collaboration, technological integration, product innovations, mergers & acquisitions, and partnerships to gain the significant market share in the industry.
In July 2018, Abbott Healthcare announced the launch of m-PIMA HIV-1/2 VL, the first viral load point-of-care test for the fast, accurate and easy-to-use test to manage HIV.
In March 2020, Johnson & Johnson’s company, The Janssen Pharmaceutical Companies announced that Health Canada has approved CABENUVA (an injectable suspensions), for the treatment of HIV-1 infection in adults.
Report Description:
As per The Brainy Insights, the size of the HIV Diagnosis market was valued at USD 3.67 billion in 2023 and is anticipated to reach USD 11.76 billion by 2033.
Global HIV Diagnosis market is growing at a CAGR of 12.35% during the forecast period 2024-2033.
The global HIV Diagnosis market has been segmented based on type, technology, end use, and regions. The consumables segment dominated the global market and held the largest market share in the year 2023.
The North America region emerged as the largest market for the HIV Diagnosis.
Increasing prevalence of HIV/AIDS across the globe is one of the significant driving factor for the growth of HIV diagnosis market.
High cost of HIV/AIDS diagnosis may hamper the growth of the market over the forecast period.
Increasing usage of home based test kits is expected to offer the future growth opportunity in the market.
Key players are Alere Inc., Abbott Healthcare, Abbvie Inc., Bristol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, BD Biosciences, Beckman Coulter, Partec, among others.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Technology
4.3.3. Market Attractiveness Analysis By End Use
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing prevalence of HIV/AIDS across the globe
5.2.2. Rising government initiative to prevent the HIV transmission
5.3. Restrains
5.3.1. High cost of nucleic acid test (NAT) HIV diagnosis
5.4. Opportunities
5.4.1. Increasing use of home test kits for the HIV diagnosis
5.5. Challenges
5.5.1. Lack of testing centers in the underdeveloped countries
6. Global HIV Diagnosis Market Analysis and Forecast, By Product
6.1. Segment Overview
6.2. Consumables
6.3. Instrument
6.4. Software And Services
7. Global HIV Diagnosis Market Analysis and Forecast, By Technology
7.1. Segment Overview
7.2. Antibody Test
7.3. Viral Load Tests
7.4. CD4 Tests
7.5. Tests For Early Infant Diagnosis
7.6. Tests For Viral Identification
8. Global HIV Diagnosis Market Analysis and Forecast, By End Use
8.1. Segment Overview
8.2. Diagnostic Laboratories
8.3. Hospitals
8.4. Blood Banks
8.5. Home Care Settings
8.6. Others
9. Global HIV Diagnosis Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global HIV Diagnosis Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in the HIV Diagnosis Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Abbott Healthcare
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Alere Inc.,
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Abbvie Inc.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Bristol-Myers Squibb
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Janssen Therapeutics
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Gilead Sciences
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Merck & Co. Inc
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. BD Biosciences
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Beckman Coulter
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Partec
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
2. Global Consumables, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
3. Global Instruments, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
4. Global Software & Services, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
5. Global HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
6. Global Antibody Test HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
7. Global Viral Load Test HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
8. Global CD4 Test HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
9. Global Test For Early Infant Diagnosis HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
10. Global Viral Identification HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
11. Global HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
12. Global Hospitals, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
13. Global Diagnostics laboratories, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
14. Global Blood Bank, HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
15. Global Home Care Settings HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
16. Global Others HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
17. Global HIV Diagnosis Market, By Region, 2020-2033 (USD Billion)
18. North America HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
19. North America HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
20. North America HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
21. U.S. HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
22. U.S. HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
23. U.S. HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
24. Canada HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
25. Canada HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
26. Canada HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
27. Mexico HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
28. Mexico HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
29. Mexico HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
30. Europe HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
31. Europe HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
32. Europe HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
33. Germany HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
34. Germany HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
35. Germany HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
36. France HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
37. France HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
38. France HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
39. U.K. HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
40. U.K. HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
41. U.K. HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
42. Italy HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
43. Italy HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
44. Italy HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
45. Spain HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
46. Spain HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
47. Spain HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
48. Asia Pacific HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
49. Asia Pacific HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
50. Asia Pacific HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
51. Japan HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
52. Japan HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
53. Japan HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
54. China HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
55. China HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
56. China HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
57. India HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
58. India HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
59. India HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
60. South America HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
61. South America HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
62. South America HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
63. Brazil HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
64. Brazil HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
65. Brazil HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
66. Middle East and Africa HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
67. Middle East and Africa HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
68. Middle East and Africa HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
69. UAE HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
70. UAE HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
71. UAE HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
72. South Africa HIV Diagnosis Market, By Product, 2020-2033 (USD Billion)
73. South Africa HIV Diagnosis Market, By Technology, 2020-2033 (USD Billion)
74. South Africa HIV Diagnosis Market, By End Use, 2020-2033 (USD Billion)
List of Figures
1. Global HIV Diagnosis Market Segmentation
2. HIV Diagnosis Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global HIV Diagnosis Market Attractiveness Analysis By Product
9. Global HIV Diagnosis Market Attractiveness Analysis By Technology
10. Global HIV Diagnosis Market Attractiveness Analysis By End Use
11. Global HIV Diagnosis Market Attractiveness Analysis By Region
12. Global HIV Diagnosis Market: Dynamics
13. Global HIV Diagnosis Market Share By Product (2023 & 2033)
14. Global HIV Diagnosis Market Share By Technology (2023 & 2033)
15. Global HIV Diagnosis Market Share By End Use (2023 & 2033)
16. Global HIV Diagnosis Market Share by Regions (2023 & 2033)
17. Global HIV Diagnosis Market Share by Company (2023)
This study forecasts revenue and volume growth at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global HIV diagnosis market on the basis of below mentioned segments:
Global HIV Diagnosis Market by Product:
Global HIV Diagnosis Market by Technology:
Global HIV Diagnosis Market by End Use:
Global HIV Diagnosis Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date